Research Paper Volume 16, Issue 1 pp 267—284
A novel disulfidptosis-related lncRNAs signature for predicting survival and immune response in hepatocellular carcinoma
Figure 7. Screening the potential sensitive chemotherapy drugs for HCC. The top 10 most significantly sensitive drugs for the high-risk group (A) and the low-risk group (B), respectively.